Published in Rheumatol Int on March 24, 2010
Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells. PLoS One (2011) 0.88
TNF-α gene polymorphisms and expression. Springerplus (2016) 0.78
TNF-α - 308 G > A and IFN-γ + 874 A > T gene polymorphisms in Egyptian patients with lupus erythematosus. Meta Gene (2016) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
The pathophysiology of tumor necrosis factors. Annu Rev Immunol (1992) 8.38
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A (1997) 6.99
TNF-mediated inflammatory disease. J Pathol (2008) 5.00
Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol (1993) 3.68
Autoimmune diseases. N Engl J Med (2001) 3.60
Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A (1990) 2.88
TNF alpha--a pivotal role in rheumatoid arthritis? Br J Rheumatol (1992) 2.34
An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med (1993) 2.30
Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proc Natl Acad Sci U S A (1987) 2.13
The genetics of human systemic lupus erythematosus. Curr Opin Immunol (1998) 1.85
Map of the human MHC. Immunol Today (1993) 1.72
Polymorphism of the human TNF-alpha promoter--random variation or functional diversity? Mol Immunol (2000) 1.57
Genetic basis of systemic lupus erythematosus. Curr Opin Immunol (1996) 1.43
Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol (1996) 1.42
The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis (1999) 1.38
Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet (2006) 1.25
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2000) 1.20
Cytokines and anti-cytokines as therapeutics--an update. Eur J Pharmacol (2007) 1.14
Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol (2005) 1.11
A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol (1994) 1.10
A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum (1997) 1.04
Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3. Scand J Rheumatol (2005) 1.02
Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens (2007) 0.95
NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens (1989) 0.94
Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol (2004) 0.92
Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers (1995) 0.92
Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol (1996) 0.91
Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis (2005) 0.90
Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum (1993) 0.90
Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism -863, but not -308 and -238, in Thai population. Int J Immunogenet (2007) 0.86
Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun (2001) 0.85
Allergic disease and autoimmune effectors pathways. Dev Immunol (2002) 0.85
HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol Int (2004) 0.84
The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE. Tissue Antigens (2007) 0.82
Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore (1996) 0.82
Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun (2001) 0.80
Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac J Allergy Immunol (2004) 0.79
Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens (1996) 0.78
Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan. J Formos Med Assoc (2005) 0.78
The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett (1997) 0.78
[Study on the association between tumor necrosis factor alpha gene polymorphism and systemic lupus erythematosus]. Zhonghua Nei Ke Za Zhi (1999) 0.76
[Tumor necrosis factor alpha in systemic lupus erythematosus: evaluation by restriction fragment length polymorphism and production by peripheral blood mononuclear cells]. Hokkaido Igaku Zasshi (1992) 0.76
[The association of sasceptibility of SLE and the gene polymorphism of TNF]. Zhonghua Yi Xue Za Zhi (1998) 0.75
[Influence of alleles and haplotypes of the main histocompatibility complex on the susceptibility to systemic lupus erythematosus in the Mexican population]. Gac Med Mex (2006) 0.75
Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). Clin Exp Rheumatol (1994) 0.75
Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus. Lupus (2002) 0.75
High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol (2003) 7.47
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet (2009) 6.42
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature (2010) 5.97
Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model. Genes Dev (2002) 3.14
Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet (2010) 2.74
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy. Radiother Oncol (2012) 2.03
A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet (2011) 1.68
Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am J Hum Genet (2012) 1.49
Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients. Rheumatol Int (2013) 1.46
Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus. Clin Rheumatol (2011) 1.44
Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev (2011) 1.38
Impact of ambient temperature on children's health: a systematic review. Environ Res (2012) 1.21
Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res (2009) 1.19
Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep (2009) 1.19
Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids (2008) 1.17
A deletion mutation in the betaA1/A3 crystallin gene ( CRYBA1/A3) is associated with autosomal dominant congenital nuclear cataract in a Chinese family. Hum Genet (2003) 1.16
Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur Neuropsychopharmacol (2010) 1.14
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem (2011) 1.14
Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr (2010) 1.09
The impact of heat waves on children's health: a systematic review. Int J Biometeorol (2013) 1.07
Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity (2013) 1.04
The risk of cancer development in systemic sclerosis: a meta-analysis. Cancer Epidemiol (2013) 1.03
Extreme temperatures and paediatric emergency department admissions. J Epidemiol Community Health (2013) 1.01
Condom use among married women at risk for sexually transmitted infections and HIV in rural China. Int J Gynaecol Obstet (2009) 1.01
Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev (2012) 1.01
Association of MicroRNA-146a with autoimmune diseases. Inflammation (2012) 1.01
Diurnal temperature range and childhood asthma: a time-series study. Environ Health (2013) 0.99
Decreased serum IL-22 levels in patients with systemic lupus erythematosus. Clin Chim Acta (2008) 0.98
3-(3-Nitro-benz-yl)-4H-chromen-4-one. Acta Crystallogr Sect E Struct Rep Online (2013) 0.97
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases. Expert Opin Ther Targets (2010) 0.97
MicroRNA-21 with therapeutic potential in autoimmune diseases. Expert Opin Ther Targets (2013) 0.96
Xanthenol clathrates: structure, thermal stability, guest exchange and kinetics of desolvation. Org Biomol Chem (2005) 0.96
Inclusion of chlorophenols by 4,4'-(cyclohexane-1,1-diyl)diphenol: structures and kinetics of decomposition. Acta Crystallogr C (2007) 0.96
Autosomal-dominant cerulean cataract in a chinese family associated with gene conversion mutation in beta-B2-crystallin. Ophthalmic Res (2009) 0.95
1,4-Bis[(2-pyridyl-eth-yl)imino-meth-yl]benzene. Acta Crystallogr Sect E Struct Rep Online (2011) 0.95
Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis. Asian Pac J Cancer Prev (2013) 0.95
Targeting IRF4 in autoimmune diseases. Autoimmun Rev (2012) 0.94
Meta-analysis of TNF-alpha promoter - 238A/G polymorphism and SLE susceptibility. Autoimmunity (2010) 0.93
Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration. Mol Ther (2007) 0.93
Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis. Cancer Invest (2011) 0.93
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications. Eur J Immunol (2014) 0.92
Controlling sulphur precursor addition for large single crystal domains of WS2. Nanoscale (2014) 0.92
IL-32 with potential insights into rheumatoid arthritis. Clin Immunol (2013) 0.92
Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers. Oncol Lett (2012) 0.92
Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol (2013) 0.92
Impact of diurnal temperature range on human health: a systematic review. Int J Biometeorol (2014) 0.91
Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese. Mol Biol Rep (2009) 0.91
The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Dev Med Child Neurol (2011) 0.91
Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo. Acad Radiol (2010) 0.91
Large single crystals of graphene on melted copper using chemical vapor deposition. ACS Nano (2012) 0.91
Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects. Eur J Cancer (2011) 0.90
The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus. Autoimmun Rev (2011) 0.90
Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients. Clin Exp Med (2011) 0.90
HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis. Bone (2013) 0.90
Extreme temperatures and emergency department admissions for childhood asthma in Brisbane, Australia. Occup Environ Med (2013) 0.89
Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience. Rheumatol Int (2011) 0.89
Influence of social support on health-related quality of life in patients with systemic lupus erythematosus. Clin Rheumatol (2008) 0.88
Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis. World J Gastroenterol (2010) 0.88
Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus. Mol Biol Rep (2010) 0.88
A new congenital nuclear cataract caused by a missense mutation in the gammaD-crystallin gene (CRYGD) in a Chinese family. Mol Vis (2005) 0.88
CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies. Prostate (2011) 0.88
Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Investig Med (2010) 0.88
D18S880 microsatellite polymorphism of carnosinase gene and diabetic nephropathy: a meta-analysis. Genet Test Mol Biomarkers (2013) 0.88
TIM-3 as a new therapeutic target in systemic lupus erythematosus. Mol Biol Rep (2010) 0.88
Is diurnal temperature range a risk factor for childhood diarrhea? PLoS One (2013) 0.88
Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol (2008) 0.88
Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6. Mol Vis (2009) 0.87
Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases. Expert Opin Ther Targets (2013) 0.87
Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis. Dig Dis Sci (2013) 0.87
Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response. Mol Cell Biol (2002) 0.87
Genetic interaction between genes involved in NF-κB signaling pathway in systemic lupus erythematosus. Mol Immunol (2013) 0.87
Prognostic value of survivin expression in breast cancer patients: a meta-analysis. Tumour Biol (2013) 0.87
A new locus for inherited nuclear cataract mapped to the long arm of chromosome 1. Mol Vis (2007) 0.87
Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders. Neurosci Lett (2010) 0.87
Risk of sexual HIV transmission among wives left behind and wives of nonmigrant men in rural areas of China. J Assoc Nurses AIDS Care (2009) 0.86
PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice. Mol Biol Rep (2012) 0.86
Climate change and children's health--a call for research on what works to protect children. Int J Environ Res Public Health (2012) 0.86
Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology (2009) 0.85